Colossal Biosciences reportedly in talks to raise new capital at $20B–$30B valuation

据称，Colossal Biosciences正在洽谈以200亿美元至300亿美元的估值筹集新资金

作者: Marina Temkin | 来源: TechCrunch | 时间: Mon, 20 Jul 2026 23:39:35 +0000

When de-extinction startup Colossal Biosciences revealed last year that it was attempting to “resurrect” the dire wolf from genetic material found in fossils, we argued that, despite the controversy surrounding the project, the company was building valuable technologies that justify its $10.2 billion valuation.

⋯ 继续阅读请登录会员 ⋯